C9408 – Iodine i-131 iobenguane, therapeutic, 1 millicurie
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9408
- Long description
- Iodine i-131 iobenguane, therapeutic, 1 millicurie
- Short description
- Iodine i-131 iobenguane, tx
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
I1EStandard imaging - nuclear medicine- Cross reference
- A9590
- Added
- January 1, 2019
- Last change
- January 1, 2020 – No change
- Termination date
- December 31, 2019
Frequently asked questions
What is HCPCS code C9408?
C9408 is a HCPCS Level II code for iodine i-131 iobenguane, therapeutic, 1 millicurie. It was discontinued on December 31, 2019.
Does Medicare cover C9408?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9359 – Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc
- C9360 – Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
- C9361 – Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length
- C9362 – Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc
- C9363 – Skin substitute, integra meshed bilayer wound matrix, per square centimeter
- C9364 – Porcine implant, permacol, per square centimeter
- C9399 – Unclassified drugs or biologicals
- C9407 – Iodine i-131 iobenguane, diagnostic, 1 millicurie
- C9441 – Injection, ferric carboxymaltose, 1 mg
- C9442 – Injection, belinostat, 10 mg
- C9443 – Injection, dalbavancin, 10 mg
- C9444 – Injection, oritavancin, 10 mg
- C9445 – Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units
- C9446 – Injection, tedizolid phosphate, 1 mg
- C9447 – Injection, phenylephrine and ketorolac, 4 ml vial
- C9448 – Netupitant 300 mg and palonosetron 0.5 mg, oral
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.